Dr Daniel Leon Gianella, MD | |
2801 Atlantic Ave, Long Beach, CA 90806-1701 | |
(562) 933-1550 | |
(562) 933-1502 |
Full Name | Dr Daniel Leon Gianella |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 20 Years |
Location | 2801 Atlantic Ave, Long Beach, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306026133 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | A93464 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Boca Raton Regional Hospital | Boca raton, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Diagnostic Centers Of America, Llp | 0547174120 | 58 |
Mori Bean And Brooks Inc | 8820077878 | 633 |
News Archive
In a report in The American Journal of Pathology investigators describe the generation of a successful novel transgenic rat model that accumulates amyloid specifically in brain blood vessels and strongly mimics many of the associated detrimental changes that are observed in humans - a condition known as cerebral amyloid angiopathy, which is also commonly observed in Alzheimer disease.
USC Annenberg announced journalism awards totaling $53,500 to support investigative and explanatory reporting projects on topics ranging from health in America's underserved communities to the challenges for health reform and quality medical care.
GP services could be compromised by new provisions enabling commercial companies to provide primary care through locally negotiated contracts, researchers warn.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.
› Verified 2 days ago
Entity Name | Mori Bean And Brooks Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093782070 PECOS PAC ID: 8820077878 Enrollment ID: O20040714001317 |
News Archive
In a report in The American Journal of Pathology investigators describe the generation of a successful novel transgenic rat model that accumulates amyloid specifically in brain blood vessels and strongly mimics many of the associated detrimental changes that are observed in humans - a condition known as cerebral amyloid angiopathy, which is also commonly observed in Alzheimer disease.
USC Annenberg announced journalism awards totaling $53,500 to support investigative and explanatory reporting projects on topics ranging from health in America's underserved communities to the challenges for health reform and quality medical care.
GP services could be compromised by new provisions enabling commercial companies to provide primary care through locally negotiated contracts, researchers warn.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.
› Verified 2 days ago
Entity Name | Diagnostic Centers Of America, Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1730125261 PECOS PAC ID: 0547174120 Enrollment ID: O20080223000067 |
News Archive
In a report in The American Journal of Pathology investigators describe the generation of a successful novel transgenic rat model that accumulates amyloid specifically in brain blood vessels and strongly mimics many of the associated detrimental changes that are observed in humans - a condition known as cerebral amyloid angiopathy, which is also commonly observed in Alzheimer disease.
USC Annenberg announced journalism awards totaling $53,500 to support investigative and explanatory reporting projects on topics ranging from health in America's underserved communities to the challenges for health reform and quality medical care.
GP services could be compromised by new provisions enabling commercial companies to provide primary care through locally negotiated contracts, researchers warn.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Leon Gianella, MD 2801 Atlantic Ave, Long Beach, CA 90806-1701 Ph: () - | Dr Daniel Leon Gianella, MD 2801 Atlantic Ave, Long Beach, CA 90806-1701 Ph: (562) 933-1550 |
News Archive
In a report in The American Journal of Pathology investigators describe the generation of a successful novel transgenic rat model that accumulates amyloid specifically in brain blood vessels and strongly mimics many of the associated detrimental changes that are observed in humans - a condition known as cerebral amyloid angiopathy, which is also commonly observed in Alzheimer disease.
USC Annenberg announced journalism awards totaling $53,500 to support investigative and explanatory reporting projects on topics ranging from health in America's underserved communities to the challenges for health reform and quality medical care.
GP services could be compromised by new provisions enabling commercial companies to provide primary care through locally negotiated contracts, researchers warn.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.
› Verified 2 days ago
Dr. Natalie Maya Sardjono, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2810 Long Beach Blvd Fl 2, Long Beach, CA 90806 Phone: 562-933-7880 | |
Young Suk Song, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2801 Atlantic Avenue, Attn: Radiology Department, Long Beach, CA 90806 Phone: 562-933-1550 | |
Dr. Thomas Charles Gates, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1043 Elm Ave, Long Beach, CA 90813 Phone: 951-691-5123 Fax: 951-691-5156 | |
Dr. Reza Lotfi, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 5901 E 7th St, Radiology 05/114, Long Beach, CA 90822 Phone: 562-826-8000 Fax: 561-826-5425 | |
Timothy V Bell, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4241 Long Beach Blvd, Rad-image Medical Group Inc., Long Beach, CA 90807 Phone: 562-912-2507 Fax: 484-918-2507 | |
Kourosh Nourisamie, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4241 Long Beach Blvd, Long Beach, CA 90807 Phone: 562-912-2507 Fax: 484-918-2507 | |
Dr. Charles Franklin Brown, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1045 Atlantic Ave, Suite 105, Long Beach, CA 90813 Phone: 562-437-6982 Fax: 562-624-0741 |